Perbedaan Brigit Biofarmaka Teknologi Tbk. dan Suparma Tbk.: Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp254 (kapitalisasi pasar 172,82 M, volume 24 jam 592,2 rb), sedangkan Suparma Tbk. diperdagangkan di Rp172 (kapitalisasi pasar 701,15 M, volume 24 jam 378 rb). Perbedaan utamanya: Suparma Tbk. jauh lebih besar — sekitar 4,1× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Brigit Biofarmaka Teknologi Tbk. lebih aktif diperdagangkan (592,2 rb vs 378 rb). Mana yang lebih baik tergantung tujuan investasimu.
| OBAT | SPMA | |
|---|---|---|
Kapitalisasi Pasar | 172,82 M | 701,15 M |
Volume | 592,2 rb | 378 rb |
Lot | 5,92 rb | 3,78 rb |
Perputaran | 147,05 jt | 64,09 jt |
Harga Rata-rata | 248,31 | 169,54 |
Nilai Transaksi | 147,05 jt | 64,09 jt |
Harga Ekuilibrium Indikatif | 254 | 171 |
Volume Ekuilibrium Indikatif | 10 | 300 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →PT Suparma Tbk (Entity) was established under the Domestic Capital Investment Law No. 6 of 1968 as amended by Law No. 12 of 1970 based on the Notarial Deed No. 29 of Tjahjadi Hartanto, S.H., on August 25, 1976. The Entity's name, PT Supar Inpama was changed to PT Suparma based in the Notarial Deed No. 5 dated December 7, 1978 of the same notary.
Selengkapnya di halaman SPMA →